Scynexis (SCYX) Liabilities from Discontinued Operations (2014 - 2015)
Scynexis (SCYX) reported Liabilities from Discontinued Operations of 2099000.0 for Q2 2015, down 13.26% quarter-over-quarter from 2420000.0 in Q4 2014.
Scynexis (SCYX) Liabilities from Discontinued Operations (2014 - 2015) Analysis & Trends
Scynexis has reported Liabilities from Discontinued Operations for 2 years, with the latest figure at 2099000.0 in Q2 2015.
- For the quarter ending Q2 2015, Liabilities from Discontinued Operations changed N/A year-over-year to 2099000.0; the trailing twelve-month figure through Jun 2015 stood at 2099000.0 (changed N/A YoY), and the FY2014 full-year result was 2420000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations for Q2 2015 stood at 2099000.0, down from 2420000.0 in the prior quarter.
- The five-year high for Liabilities from Discontinued Operations was 2420000.0 in Q4 2014, with the low at 2099000.0 in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Scynexis | 225.23 Mn | 165.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 2.10 Mn |
| Jun 30, 2015 | 2.10 Mn |
| Dec 31, 2014 | 2.42 Mn |
| Dec 31, 2014 | 2.42 Mn |